图 书 馆
C9orf72 ALS的临床、病理和分子特征导致新的治疗靶点的确定Clinical, pathological and molecular characterisation of C9orf72-ALS leads to identification of novel therapeutic targets |
|
| 课程网址: | http://videolectures.net/encals2017_cooper_knock_investigator_awa... |
| 主讲教师: | Johnathan Cooper-Knock |
| 开课单位: | 雪菲尔大学 |
| 开课时间: | 2017-09-22 |
| 课程语种: | 英语 |
| 中文简介: |  |
| 课程简介: | Johnathan Cooper-Knock works as a clinical research fellow at SITRAN, the Sheffield Institute for Translational Neuroscience in Sheffield, UK. His interest is in studying the changes to gene expression as a way of better understanding MND/ ALS and identifying therapeutic targets. In particular his work has focused on the most common genetic variant associated with abnormal expansion of the gene C9ORF72. After receiving the award Johnathan presented an overview of his work titled ‘Clinical, pathological and molecular characterisation of C9orf72-ALS leads to identification of novel therapeutic targets’. The ENCALS young investigator award was designed to recognize the brightest and best young scientists in ALS, and is given for outstanding research. It is judged by the ENCALS award committee, an international panel of experts. Criteria include any or all of novelty, challenge to existing ideas about ALS, results with patient benefit, and impact on our understanding of ALS. |
| 关 键 词: | 治疗靶点; 基因变异; ALS |
| 课程来源: | 视频讲座网 |
| 数据采集: | 2021-12-10：zkj |
| 最后编审: | 2021-12-10：zkj |
| 阅读次数: | 51 |